Drug or treatment
Tinengotinib clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Tinengotinib that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Tinengotinib plus fulvestrant for HR-positive, HER2-negative recurrent or metastatic breast cancer
This will test whether adding the oral drug tinengotinib to fulvestrant helps people with HR-positive, HER2-negative advanced breast cancer who have not responded to prior treatments.
-
Combining Tinengotinib with Standard Treatments for Prostate Cancer
This study is testing if adding tinengotinib to standard prostate cancer treatments can help men with advanced prostate cancer feel better and improve their outcomes.
Quick answers
How many clinical trials of Tinengotinib are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.